‘Tariff chaos’ but pharmaceuticals may stay outside the fray
The United States Supreme Court's decision to strike down President Trump’s tariffs imposed under the International Emergency Economic Powers Act (IEEPA) was greeted by many as a sign that constitutional checks and balances were still in working order.
However, anyone thinking that this might bring a turnaround in Trump’s thinking on tariffs were swiftly disabused of this notion by an announcement that he would impose a 10% tariff on all goods entering the US. By Saturday, Trump said this should be raised to 15%.
The new measures rely on Section 122 of the 1974 US Trade Act, which allows temporary tariffs to address serious balance-of-payments deficits, and can only be extended beyond 150 days with the approval of the...

Share this article:
Advertising by Adpathway




